{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:23:59Z","timestamp":1789752239752,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.thromres.2016.11.011","type":"journal-article","created":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T18:31:54Z","timestamp":1478889114000},"page":"17-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Febuxostat attenuates paroxysmal atrial fibrillation-induced regional endothelial dysfunction"],"prefix":"10.1016","volume":"149","author":[{"given":"YanGuang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FuKun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zhaoliang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuTang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2016.11.011_bb0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"issue":"9658","key":"10.1016\/j.thromres.2016.11.011_bb0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2016.11.011_bb0015","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCEP.114.003057","article-title":"Atrial fibrillation burden and short-term risk of stroke: a case-crossover analysis of continuously recorded heart rhythm from cardiac electronic implanted devices","volume":"8","author":"Turakhia","year":"2015","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"2016","key":"10.1016\/j.thromres.2016.11.011_bb0020","first-page":"65","article-title":"Atrial fibrillation and silent stroke: links, risks, and challenges","volume":"12","author":"Hahne","year":"2016","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.thromres.2016.11.011_bb0025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0735-1097(95)80062-X","article-title":"Coagulation activity is increased in the left atrium of patients with mitral stenosis","volume":"26","author":"Lip","year":"1995","journal-title":"JACC"},{"key":"10.1016\/j.thromres.2016.11.011_bb0030","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.hrthm.2010.01.042","article-title":"Atrial platelet reactivity in patients with atrial fibrillation","volume":"7","author":"Willoughby","year":"2010","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.thromres.2016.11.011_bb0035","first-page":"4","article-title":"Oxidative stress biomarkers and incidence of postoperative atrial fibrillation in the omega-3 fatty acids for prevention of postoperative atrial fibrillation(OPERA) trial","author":"Wu","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.thromres.2016.11.011_bb0040","first-page":"4","article-title":"Defining the links between oxidative stress-Based biomarkers and postoperative atrial fibrillation","author":"Lubbers","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.thromres.2016.11.011_bb0045","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/CIRCULATIONAHA.105.538108","article-title":"Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases","volume":"112","author":"Dudley","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2016.11.011_bb0050","article-title":"Xanthine oxidase inhibitor, allopurinol, prevented oxidative stress, fibrosis and myocardial damage in isoproterenol induced aged rats","volume":"478039","author":"Sagor","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.thromres.2016.11.011_bb0055","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fphys.2012.00150","article-title":"Xanthine oxidase and uric acid in atrial fibrillation","volume":"3","author":"Korantzopoulos","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.thromres.2016.11.011_bb0060","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2165\/00003088-200645080-00005","article-title":"Parmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects","volume":"45","author":"Khosravan","year":"2006","journal-title":"Clin. Pharmacokinet."},{"issue":"11","key":"10.1016\/j.thromres.2016.11.011_bb0065","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1161\/CIRCULATIONAHA.112.000826","article-title":"Deletion of the activated protein-1 transcription factor JunD induces oxidative stress and accelerates age-related endothelial dysfunction","volume":"127","author":"Francesco","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2016.11.011_bb0070","article-title":"Renal denervation suppresses atrial fibrillation in a model of renal impairment[J]","volume":"10","author":"Liang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2016.11.011_bb0075","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.hrthm.2015.03.010","article-title":"Alogliptin, a dipeptidyl peptidase-4 inhibitor, regulates the atrial arrhythmogenic substrate in rabbits","volume":"12","author":"Yamamoto","year":"2015","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.thromres.2016.11.011_bb0080","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1161\/01.CIR.102.20.2503","article-title":"Effect of digoxin on acute atrial refractoriness","volume":"102","author":"Sticherling","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2016.11.011_bb0085","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.thromres.2015.05.028","article-title":"Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation","volume":"136","author":"Drabik","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2016.11.011_bb0090","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2174\/1381612820666140825143028","article-title":"Endothelial (dys)function in lone atrial fibrillation","volume":"21","author":"Polovina","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.thromres.2016.11.011_bb0095","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2010.12.033","article-title":"Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients","volume":"57","author":"Roldan","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2016.11.011_bb0100","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1161\/01.CIR.0000102969.09658.F2","article-title":"Thrombomodulin and tissue factor pathway inhibitor in endocardium of rapidly paced rat atria","volume":"108","author":"Yamashita","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2016.11.011_bb0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijcard.2010.09.004","article-title":"The impact of rapid atrial pacing on ADMA and endothelial NOS","volume":"154","author":"Goette","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.thromres.2016.11.011_bb0110","article-title":"Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2016.11.011_bb0115","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/europace\/eut121","article-title":"Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients","volume":"15","author":"Scridon","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.thromres.2016.11.011_bb0120","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jacc.2007.11.083","article-title":"Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction","volume":"51","author":"Akar","year":"2008","journal-title":"JACC"},{"key":"10.1016\/j.thromres.2016.11.011_bb0125","first-page":"223","article-title":"Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study","volume":"44","author":"Enta","year":"2004","journal-title":"J. Cardiol."},{"key":"10.1016\/j.thromres.2016.11.011_bb0130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2013.11.051","article-title":"Hyperuricemia and risk of stroke: a systemic review and meta-analysis of prospective studies","volume":"232","author":"Li","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2016.11.011_bb0135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jns.2010.07.007","article-title":"High levels of serum uric acid are associated with silent brain infarction","volume":"297","author":"Heo","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.thromres.2016.11.011_bb0140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.RES.0000183735.09871.61","article-title":"A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation","volume":"97","author":"Kim","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.thromres.2016.11.011_bb0145","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1540-8167.2003.03070.x","article-title":"Molecular basis of atrial fibrillation: a dream or a reality?","volume":"14","author":"Van Wagonder","year":"2003","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.thromres.2016.11.011_bb0150","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.2174\/138161205774913255","article-title":"Uric acid and oxidative stress","volume":"11","author":"Glantzounis","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.thromres.2016.11.011_bb0155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/CRD.0b013e318229a908","article-title":"Allopurinol as a cardiovascular drug","volume":"19","author":"Kelkar","year":"2011","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.thromres.2016.11.011_bb0160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2011.04.004","article-title":"Febuxostat inhibition of endothelial-bound XO: implications for targeting vascular ROS production","volume":"51","author":"Malik","year":"2011","journal-title":"Free Radic. Biol. Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384816306223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384816306223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T19:59:33Z","timestamp":1536263973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384816306223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":32,"alternative-id":["S0049384816306223"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2016.11.011","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Febuxostat attenuates paroxysmal atrial fibrillation-induced regional endothelial dysfunction","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2016.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}